Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018 - KHGI-TV/KWNB-TV/KHGI-CD-Grand Island, Kearney, Hastings

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, May 29, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

http://www.reportlinker.com/p02116809/Animal-Antimicrobials-and-Antibiotics-Market-by-Products-Tetracyclines-Penicillins-Sulfonamides-Aminoglycosides-Animals-Dog-Poultry-Swine-Mode-Of-Delivery-Premixes-Oral-Powders-and-Solutions-Injections---Global-Forecasts-to-2018.html

Antimicrobials and antibiotics form a major share of the animal health market. Animal antimicrobials gained a greater importance in the animal health industry in the past 20 years, mainly due to growing need to preserve the health and welfare of animals. Most of the antimicrobial agents were also used as growth promoters as well. With this, the animal antimicrobials market witnessed a bullish growth from 1990's to 2006.

However, gradually, there were growing concerns about emergence of antibiotic-resistant bacteria which led to worldwide initiatives to minimize the use of antimicrobial agents as a growth promoter in food-producing animals. In Europe, in 2006, a complete ban was imposed on use of antimicrobial agents in food-producing animals, which brought a huge setback to the growing market for antimicrobial and antibiotics in Europe.

At present, the global antimicrobials and antibiotics market is driven by the growing need to preserve animal health owing to rising demand for animal proteins across the globe, and growing demand in the companion animals segment. Growing livestock population, increasing incidences of disease outbreaks and increase in the companion animal ownership are some of the factors driving the growth of this market to a certain extent. Besides the structural market drivers, there are strong geographic drivers for the growth of the animal antimicrobials and antibiotics market. The emerging markets are becoming increasingly attractive. The Asian and Latin American region form one of the most promising animal antimicrobials and antibiotics markets in the world. Developing countries such as China and India have a relatively high CAGR rate and are expected to witness significant market growth in the forecast period. The growth in these regions is mainly attributed to the rise in demand for animal protein products, along with an increase in the trend of companion animal ownership in these regions.

Today, the animal antimicrobials and antibiotics market showcase a sluggish growth, owing to the regulatory authorities restricting their use, increased usage of in-feed enzymes, competitive exclusion products and probiotics as an alternative to antibiotics and prophylactic use of antibiotics being replaced by good husbandry, environment and hygienic practices.
Tetracyclines dominated the animal antimicrobials and antibiotics product segment in 2013, accounting for around 60% of the market revenue. This was followed by others segment, which accounted for 16% of the global animal antimicrobials and antibiotics product market in 2013. In the global antimicrobials and antibiotics animal market, pigs dominated the market with a share of close to 25%. In the mode of delivery segment of animal antimicrobials and antibiotics market, premix was the major revenue contributor in 2013, with an estimated share of nearly 49%.

North America dominated the animal antimicrobials and antibiotics market in 2013. However, the market share of this region will decrease to 27%, primarily due to the regulatory ban on the use of antibiotics announced in the U.S. At the same time, Asia and Latin America are poised to grow at a CAGR of 6% to 8% in the forecast period; this growth is largely driven by the increased urbanization, rising disposable incomes, increase in the demand for animal products and the increasing trend of pet ownerships in these regions.

The global animal antimicrobials and antibiotics market is consolidated with Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.), Bayer Animal Health (Germany) holding around 75% of the total market. Other major players in this market are Virbac Animal Health (U.S.), and CEVA Santé Animale (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the animal antimicrobials and antibiotics market. The report analyzes the animal antimicrobials and antibiotics market by animals type, mode of delivery type and by product type across all geographies.

• Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the animal antimicrobials and antibiotics market.

• Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.

• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the animal antimicrobials and antibiotics market.

• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the animal antimicrobials and antibiotics market.

1 INTRODUCTION 22

1.1 OBJECTIVES OF THE STUDY 22
1.2 REPORT DESCRIPTION 22
1.3 MARKETS COVERED 24
1.4 STAKEHOLDERS 25
1.5 RESEARCH METHODOLOGY 26
1.5.1 MARKET SIZE ESTIMATION 28
1.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 29
1.5.3 MARKET SHARE ESTIMATION 30
1.5.4 KEY DATA FROM SECONDARY SOURCES 31
1.5.5 KEY DATA POINTS FROM PRIMARY SOURCES 31
1.5.6 ASSUMPTIONS 33

2 EXECUTIVE SUMMARY 35

3 PREMIUM INSIGHTS 39

3.1 GROWING CONSUMPTION OF ANIMAL PROTEIN PRODUCTS PROVIDES SIGNIFICANT GROWTH OPPORTUNITIES FOR ANTIMICROBIALS MARKET 39
3.2 GROWING PER CAPITA COMPANION ANIMAL HEALTH EXPENDITURE TO DRIVE THE MARKET GROWTH 40
3.3 REGULATORY BAN ON UNAUTHORIZED USAGE OF ANTIBIOTICS CURBING THE GROWTH 41
3.4 HIGH-GROWTH POTENTIAL OF EMERGING MARKETS IN ASIA-PACIFIC, MIDDLE EAST, AND LATIN AMERICA 42

4 MARKET OVERVIEW 44

4.1 INTRODUCTION 45
4.2 MARKET SEGMENTATION 46
4.3 MARKET DYNAMICS 47
4.3.1 KEY MARKET DRIVERS 47
4.3.1.1 Rising demand for livestock products due to growing livestock population worldwide 47
4.3.1.2 Increasing incidences of animal disease outbreaks leading to high utilization of antibiotics 48
4.3.1.3 Increased use of approved antimicrobial agents to promote growth and feed efficiency in food animals 49
4.3.1.4 Growing demand for animal antimicrobials in China 49
4.3.1.5 Increase in companion animal ownership across the world 50
4.3.2 KEY MARKET RESTRAINTS 50
4.3.2.1 Regulatory authorities curbing the growth of antimicrobials and antibiotics market 50
4.3.2.2 Dearth of new antibiotics in the market 51
4.3.2.3 Routine prophylactic use of antibiotics being replaced by good husbandry and hygiene practices 52
4.3.2.4 Increased use of in-feed enzymes and competitive exclusion products or probiotics as alternatives to antibiotics 53
4.3.3 KEY MARKET OPPORTUNITIES 54
4.3.3.1 Growing demand for pet animals in the emerging markets 54
4.3.3.2 Rapid growth in pet health insurance is driving the animal antimicrobials and antibiotics market 54
4.4 GLOBAL MARKET SHARE ANALYSIS 55

5 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT 58

5.1 INTRODUCTION 59
5.1.1 TETRACYCLINES 60
5.1.2 PENICILLINS 62
5.1.3 SULFONAMIDES 64
5.1.4 MACROLIDES 66
5.1.5 AMINOGLYCOSIDES 68
5.1.6 CEPHALOSPORINS 69
5.1.7 OTHERS 71

6 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY 74

6.1 INTRODUCTION 75
6.1.1 PREMIXES 76
6.1.2 ORAL POWDERS & SOLUTIONS 78
6.1.3 INJECTIONS 80
6.1.4 INTRAMAMMARY PREPARATIONS 82
6.1.5 OTHER PREPARATIONS 83

7 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL 86

7.1 INTRODUCTION 87
7.2 FOOD-PRODUCING ANIMALS 89
7.2.1 CATTLE 91
7.2.2 PIGS 93
7.2.3 POULTRY 95
7.2.4 SHEEP AND GOATS 97
7.3 COMPANION ANIMALS 99
7.3.1 DOGS 102
7.3.2 CATS 103
7.3.3 HORSES 105
7.4 OTHER ANIMALS 107

8 GEOGRAPHIC ANALYSIS 110

8.1 INTRODUCTION 111
8.1.1 NORTH AMERICA 112
8.1.1.1 U.S. 119
8.1.1.2 Canada 124
8.1.2 EUROPE 129
8.1.2.1 U.K. 135
8.1.2.2 Germany 140
8.1.2.3 France 145
8.1.2.4 Italy 150
8.1.2.5 Spain 155
8.1.2.6 Rest of Europe 160
8.1.3 ASIA-PACIFIC 165
8.1.3.1 Japan 172
8.1.3.2 China 177
8.1.3.3 India 183
8.1.3.4 Rest of Asia-Pacific 188
8.1.4 REST OF THE WORLD (ROW) 193
8.1.4.1 Latin America 199
8.1.4.2 Middle East And Africa 204

9 COMPETITIVE LANDSCAPE 210

9.1 INTRODUCTION 210
9.2 MERGERS AND ACQUISITIONS 213
9.3 NEW PRODUCT LAUNCHES 215
9.4 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 217
9.5 EXPANSIONS 219
9.6 OTHERS 220

10 COMPANY PROFILES 222 (Overview, Financials, Products & Services, Strategy, & Developments)*

10.1 ZOETIS, INC. 222
10.2 MERCK AND CO., INC. 229
10.3 BAYER AG 236
10.4 VIRBAC SA 245
10.5 ELI LILLY AND COMPANY 252
10.6 BOEHRINGER INGELHEIM 259
10.7 SANOFI 266
10.8 NOVARTIS AG 276
10.9 CEVA SANTE ANIMALE 283
10.10 VETOQUINOL 289
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 60
TABLE 2 GLOBAL TETRACYCLINES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 61
TABLE 3 GLOBAL PENICILLINS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 63
TABLE 4 GLOBAL SULFONAMIDES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 65
TABLE 5 GLOBAL MACROLIDES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 66
TABLE 6 GLOBAL AMINOGLYCOSIDES MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 68
TABLE 7 GLOBAL CEPHALOSPORINS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 70
TABLE 8 GLOBAL OTHERS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 72
TABLE 9 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 76
TABLE 10 GLOBAL PREMIXES MARKET FOR ANIMAL ANTIMICROBIALS AND ANTIBIOTICS, BY GEOGRAPHY, 2011–2018 ($MILLION) 77
TABLE 11 GLOBAL ORAL POWDERS AND SOLUTIONS MARKET FOR ANIMAL ANTIMICROBIALS AND ANTIBIOTICS, BY GEOGRAPHY,
2011–2018 ($MILLION) 79
TABLE 12 GLOBAL INJECTIONS MARKET FOR ANIMAL ANTIMICROBIALS AND ANTIBIOTICS, BY GEOGRAPHY, 2011–2018 ($MILLION) 81
TABLE 13 GLOBAL INTRAMAMMARY PREPARATIONS MARKET FOR ANIMAL ANTIMICROBIALS AND ANTIBIOTICS, BY GEOGRAPHY,
2011–2018 ($MILLION) 82
TABLE 14 GLOBAL OTHER PREPARATIONS MARKET FOR ANIMAL ANTIMICROBIALS AND ANTIBIOTICS, BY GEOGRAPHY, 2011–2018 ($MILLION) 84
TABLE 15 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 88
TABLE 16 GLOBAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 89
TABLE 17 GLOBAL FOOD-PRODUCING ANIMALS ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2011–2018 ($MILLION) 90
TABLE 18 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATTLE, BY COUNTRY, 2011–2018 ($MILLION) 92
TABLE 19 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR PIGS, BY COUNTRY, 2011–2018 ($MILLION) 94
TABLE 20 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR POULTRY, BY COUNTRY, 2011–2018 ($MILLION) 96
TABLE 21 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2011–2018 ($MILLION) 98
TABLE 22 GLOBAL COMPANION ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 100
TABLE 23 GLOBAL COMPANION ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2011–2018 ($MILLION) 101
TABLE 24 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR DOGS, BY COUNTRY, 2011–2018 ($MILLION) 102
TABLE 25 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR CATS, BY COUNTRY, 2011–2018 ($MILLION) 104
TABLE 26 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR HORSES, BY COUNTRY, 2011–2018 ($MILLION) 106
TABLE 27 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS FOR OTHER ANIMALS (FISHES AND RABBITS) MARKET, BY COUNTRY,
2011–2018 ($MILLION) 108
TABLE 28 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY GEOGRAPHY, 2011–2018 ($MILLION) 112
TABLE 29 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY COUNTRY, 2011–2018 ($MILLION) 114
TABLE 30 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 115
TABLE 31 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2011–2018 ($MILLION) 116
TABLE 32 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 117
TABLE 33 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 118
TABLE 34 NORTH AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 119
TABLE 35 U.S.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 120
TABLE 36 U.S.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 121
TABLE 37 U.S.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 122
TABLE 38 U.S.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 123
TABLE 39 U.S.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 124
TABLE 40 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 125
TABLE 41 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 126
TABLE 42 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 127
TABLE 43 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 128
TABLE 44 CANADA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 129
TABLE 45 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 130
TABLE 46 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 131
TABLE 47 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 132
TABLE 48 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 133
TABLE 49 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 134
TABLE 50 EUROPE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 135
TABLE 51 U.K.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 136
TABLE 52 U.K.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 137
TABLE 53 U.K.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 138
TABLE 54 U.K.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 139
TABLE 55 U.K.: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 140
TABLE 56 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 141
TABLE 57 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 142
TABLE 58 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 143
TABLE 59 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 144
TABLE 60 GERMANY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 145
TABLE 61 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 146
TABLE 62 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 147
TABLE 63 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 148
TABLE 64 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 149
TABLE 65 FRANCE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 150
TABLE 66 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET
BY PRODUCT, 2011–2018 ($MILLION) 151
TABLE 67 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 152
TABLE 68 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 153
TABLE 69 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 154
TABLE 70 ITALY: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 155
TABLE 71 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 156
TABLE 72 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 157
TABLE 73 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 158
TABLE 74 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 159
TABLE 75 SPAIN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 160
TABLE 76 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 161
TABLE 77 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 162
TABLE 78 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 163
TABLE 79 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 164
TABLE 80 ROE: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 165
TABLE 81 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY COUNTRY, 2011–2018 ($MILLION) 167
TABLE 82 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 168
TABLE 83 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY , 2011–2018 ($MILLION) 169
TABLE 84 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 170
TABLE 85 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 171
TABLE 86 APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 172
TABLE 87 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 173
TABLE 88 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 174
TABLE 89 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 175
TABLE 90 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 176
TABLE 91 JAPAN: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 177
TABLE 92 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 179
TABLE 93 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 180
TABLE 94 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 181
TABLE 95 CHINA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 182
TABLE 96 CHINA : ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 183
TABLE 97 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 184
TABLE 98 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 185
TABLE 99 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 186
TABLE 100 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 187
TABLE 101 INDIA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 188
TABLE 102 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCTS, 2011–2018 ($MILLION) 189
TABLE 103 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2011–2018 ($MILLION) 190
TABLE 104 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 191
TABLE 105 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 192
TABLE 106 REST OF APAC: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 193
TABLE 107 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 194
TABLE 108 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT, 2011–2018 ($MILLION) 195
TABLE 109 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY MODE OF DELIVERY, 2011–2018 ($MILLION) 196
TABLE 110 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 197
TABLE 111 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 198
TABLE 112 ROW: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 199
TABLE 113 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 200
TABLE 114 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2011–2018 ($MILLION) 201
TABLE 115 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 202
TABLE 116 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION)) 203
TABLE 117 LATIN AMERICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS, BY TYPE OF ANIMAL,
2011–2018 ($MILLION) 204
TABLE 118 MIDDLE EAST AND AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY PRODUCT, 2011–2018 ($MILLION) 205
TABLE 119 MIDDLE EAST AND AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY MODE OF DELIVERY, 2011–2018 ($MILLION) 206
TABLE 120 MIDDLE EAST AND AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET, BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 207
TABLE 121 MIDDLE EAST AND AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR FOOD-PRODUCING ANIMALS,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 208
TABLE 122 MIDDLE EAST AND AFRICA: ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET FOR COMPANION ANIMALS,
BY TYPE OF ANIMAL, 2011–2018 ($MILLION) 209
TABLE 123 GROWTH STRATEGY MATRIX, 2010–2014 211
TABLE 124 MERGERS AND ACQUISITIONS, 2012–2013 213
TABLE 125 NEW PRODUCT LAUNCHES, 2010–2014 215
TABLE 126 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2010–2014 217
TABLE 127 EXPANSIONS, 2010–2014 219
TABLE 128 OTHER DEVELOPMENTS, 2010–2014 220

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 27
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 29
FIGURE 3 DATA TRIANGULATION METHODOLOGY 30
FIGURE 4 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY PRODUCT TYPE, 2013 VS 2018 ($MILLION) 36
FIGURE 5 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET,
BY ANIMAL TYPE , 2013 VS 2018 ($MILLION) 37
FIGURE 6 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET: HIGH-GROWTH MARKETS, 2013 38
FIGURE 7 PROJECTED GLOBAL CONSUMPTION OF MEAT AND DAIRY PRODUCTS, 2010–2050 40
FIGURE 8 GLOBAL ANTIMICROBIALS AND ANTIBIOTICS MARKET REVENUE TREND, 2011–2018 ($MILLION) 42
FIGURE 9 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SEGEMENTATION 46
FIGURE 10 GLOBAL ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET SHARE ANALYSIS, 2013 55
FIGURE 11 KEY GROWTH STRATEGIES OF ANIMAL ANTIMICROBIAL AND ANTIBIOTICS MARKET, 2010–2014 210
FIGURE 12 ZOETIS, INC.: TOTAL BUSINESS REVENUE ($MILLION), 2011–2013 224
FIGURE 13 ZOETIS, INC.: REVENUE, BY BUSINESS, 2013 225
FIGURE 14 ZOETIS, INC.: BUSINESS REVENUE, BY GEOGRAPHY, 2013 226
FIGURE 15 MERCK AND CO., INC.: TOTAL BUSINESS REVENUE($MILLION),
2011–2013 231
FIGURE 16 MERCK AND CO., INC.: REVENUE, BY BUSINESS, 2013 232
FIGURE 17 MERCK AND CO., INC.: BUSINESS REVENUE, BY GEOGRAPHY, 2013 233
FIGURE 18 BAYER AG: REVENUE SEGMENTATION, 2013 238
FIGURE 19 BAYER CONSUMER HEALTH: TOTAL BUSINESS REVENUE ($MILLION), 2011–2013 239
FIGURE 20 BAYER CONSUMER HEALTH: REVENUE, BY BUSINESS, 2013 240
FIGURE 21 BAYER CONSUMER HEALTH: BUSINESS REVENUE, BY GEOGRAPHY, 2013 241
FIGURE 22 VIRBAC SA: BUSINESS REVENUE ($MILLION), 2010-2012 247
FIGURE 23 VIRBAC SA: REVENUE, BY BUSINESS, 2012 248
FIGURE 24 VIRBAC SA: BUSINESS REVENUE, BY GEOGRAPHY, 2012 249
FIGURE 25 ELI LILLY AND COMPANY: ELANCO ANIMAL HEALTH BUSINESS REVENUE ($MILLION), 2011–2013 254
FIGURE 26 ELI LILLY AND COMPANY: TOTAL REVENUE, BY BUSINESS, 2013 255
FIGURE 27 ELI LILLY AND COMPANY:ELANCO ANIMAL HEALTHBUSINESS REVENUE, BY GEOGRAPHY, 2013 256
FIGURE 28 BOEHRINGER INGELHEIM: REVENUE SEGMENTATION, 2012 261
FIGURE 29 BOEHRINGER INGELHEIM: TOTAL BUSINESS REVENUE ($MILLION), 2010–2012 262
FIGURE 30 BOEHRINGER INGELHEIM: REVENUE, BY BUSINESS, 2012 263
FIGURE 31 BOEHRINGER INGELHEIM: ANIMAL HEALTH BUSINESS REVENUE,
BY GEOGRAPHY, 2012 264
FIGURE 32 SANOFI: REVENUE SEGMENTATION, 2013 268
FIGURE 33 MERIAL: TOTAL BUSINESS REVENUE ($MILLION), 2011–2013 269
FIGURE 34 MERIAL: REVENUE, BY BUSINESS, 2013 270
FIGURE 35 MERIAL: BUSINESS REVENUE, BY GEOGRAPHY, 2013 271
FIGURE 36 NOVARTIS AG: REVENUE SEGMENTATION, 2013 278
FIGURE 37 NOVARTIS CONSUMER HEALTH: TOTAL BUSINESS REVENUE($MILLION), 2011–2013 278
FIGURE 38 NOVARTIS AG: REVENUE, BY BUSINESS, 2013 279
FIGURE 39 NOVARTIS CONSUMER HEALTH: BUSINESS REVENUE, BY GEOGRAPHY, 2013 280
FIGURE 40 CEVA SANTE ANIMALE: TOTAL BUSINESS REVENUE ($MILLION),
2010–2012 285
FIGURE 41 CEVA SANTE ANIMALE: BUSINESS REVENUE, BY GEOGRAPHY, 2012 286
FIGURE 42 VETOQUINOL: BUSINESS REVENUE ($MILLION), 2011–2013 291
FIGURE 43 VETOQUINOL: BUSINESS REVENUE, BY GEOGRAPHY, 2013 292

To order this report: Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018
http://www.reportlinker.com/p02116809/Animal-Antimicrobials-and-Antibiotics-Market-by-Products-Tetracyclines-Penicillins-Sulfonamides-Aminoglycosides-Animals-Dog-Poultry-Swine-Mode-Of-Delivery-Premixes-Oral-Powders-and-Solutions-Injections---Global-Forecasts-to-2018.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General and news information or questions:
Across the Midlands Information:
events@nebraska.tv
Comments: comments@nebraska.tv
News:
news@nebraska.tv
Phone: 308-743-2494
News Fax: 308-743-2660
All content © Copyright 2000 - 2014 WorldNow and NTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.